The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
Perioperative celecoxib, combined with opioids, is an effective and safe regimen for pain control in TKA patients. Perioperative celecoxib can significantly decrease postoperative pain scores at ...
However, placebo usage may present ethical concerns in the postoperative care of TKA surgery; we therefore adopted an active-control trial design that compared celebrex treatment to the standard ...
Arthritis is a condition that causes inflammation and cartilage loss within the joint. There are several types of arthritis. The most common type—osteoarthritis, or wear-and-tear arthritis—occurs ...
Joint pain—whether due to injury, infection, or arthritis—can make everyday activities uncomfortable, if not impossible. Addressing your joint pain and the inflammation that may be causing it ...